BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12707369)

  • 1. Cryptic CTL epitope on a murine sarcoma Meth A generated by exon extension as a novel mechanism.
    Uenaka A; Hirano Y; Hata H; Win S; Aji T; Tanaka M; Ono T; Skipper JC; Shimizu K; Nakayama E
    J Immunol; 2003 May; 170(9):4862-8. PubMed ID: 12707369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine leukemia RL male 1 and sarcoma Meth A antigens recognized by cytotoxic T lymphocytes (CTL).
    Uenaka A; Nakayama E
    Cancer Sci; 2003 Nov; 94(11):931-6. PubMed ID: 14611667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.
    Frassanito MA; Mayordomo JI; DeLeo RM; Storkus WJ; Lotze MT; DeLeo AB
    Cancer Res; 1995 Jan; 55(1):124-8. PubMed ID: 7528638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.
    Rimoldi D; Rubio-Godoy V; Dutoit V; Lienard D; Salvi S; Guillaume P; Speiser D; Stockert E; Spagnoli G; Servis C; Cerottini JC; Lejeune F; Romero P; Valmori D
    J Immunol; 2000 Dec; 165(12):7253-61. PubMed ID: 11120859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.
    Ono T; Sato S; Kimura N; Tanaka M; Shibuya A; Old LJ; Nakayama E
    Int J Cancer; 2000 Dec; 88(6):845-51. PubMed ID: 11093803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a second major tumor-specific antigen recognized by CTLs on mouse mastocytoma P815.
    Bilsborough J; Van Pel A; Uyttenhove C; Boon T; Van den Eynde BJ
    J Immunol; 1999 Mar; 162(6):3534-40. PubMed ID: 10092811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame.
    Slager EH; Borghi M; van der Minne CE; Aarnoudse CA; Havenga MJ; Schrier PI; Osanto S; Griffioen M
    J Immunol; 2003 Feb; 170(3):1490-7. PubMed ID: 12538712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes.
    Kawakami Y; Wang X; Shofuda T; Sumimoto H; Tupesis J; Fitzgerald E; Rosenberg S
    J Immunol; 2001 Feb; 166(4):2871-7. PubMed ID: 11160356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and Identification of an H-2K
    Ma RX; Cheng LF; Ying QK; Liu RR; Ma TJ; Zhang XX; Liu ZY; Zhang L; Ye W; Zhang FL; Xu ZK; Wang F; Wu XA
    Front Cell Infect Microbiol; 2016; 6():151. PubMed ID: 27933274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts.
    Nagata Y; Furugen R; Hiasa A; Ikeda H; Ohta N; Furukawa K; Nakamura H; Furukawa K; Kanematsu T; Shiku H
    J Immunol; 1997 Aug; 159(3):1336-43. PubMed ID: 9233630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cloned class I MHC-restricted, CD8+ anti-Meth A cytotoxic T-lymphocytes: recognition of an epitope derived from the Meth A gp110 tumor rejection antigen.
    Fassanito MA; Loftus D; De Leo RM; Law LW; Appella E; De Leo AB
    Cancer Res; 1994 Aug; 54(16):4424-9. PubMed ID: 7519121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage.
    Lupetti R; Pisarra P; Verrecchia A; Farina C; Nicolini G; Anichini A; Bordignon C; Sensi M; Parmiani G; Traversari C
    J Exp Med; 1998 Sep; 188(6):1005-16. PubMed ID: 9743519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELISPOT cloning of tumor antigens recognized by cytotoxic T-lymphocytes from a cDNA expression library.
    Uenaka A; Hata H; Win S; Ono T; Wada H; Nakayama E
    Cancer Immun; 2001 Jul; 1():8. PubMed ID: 12747769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
    Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen.
    Rice J; Buchan S; Stevenson FK
    J Immunol; 2002 Oct; 169(7):3908-13. PubMed ID: 12244189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping of full-length glycoprotein D from HSV-2 reveals a novel CD4+ CTL epitope located at the transmembrane-cytoplasmic junction.
    Cooper D; Mester JC; Guo M; Nasar F; Souza V; Dispoto S; Sidhu M; Hagen M; Eldridge JH; Natuk RJ; Pride MW
    Cell Immunol; 2006 Feb; 239(2):113-20. PubMed ID: 16762332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens.
    Dudley ME; Roopenian DC
    J Exp Med; 1996 Aug; 184(2):441-7. PubMed ID: 8760797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes.
    Schirmbeck R; Stober D; El-Kholy S; Riedl P; Reimann J
    J Immunol; 2002 Jun; 168(12):6253-62. PubMed ID: 12055239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crossrecognition by CD8 T cell receptor alpha beta cytotoxic T lymphocytes of peptides in the self and the mycobacterial hsp60 which share intermediate sequence homology.
    Zügel U; Schoel B; Yamamoto S; Hengel H; Morein B; Kaufmann SH
    Eur J Immunol; 1995 Feb; 25(2):451-8. PubMed ID: 7875208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66].
    Jin S; Wang Y; Wang SJ; Zhang HZ; Li MX; Chen Y; Ge HL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):233-6, 242. PubMed ID: 15766414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.